Skip to main content

Search Results

out of 9 results
Other SAMHSA Data Set
Collected Date: 2017-2019
Report Type: Spotlight, Evaluation

This CBHSQ Spotlight presents findings from an evaluation of the State Pilot Program for Treatment for Pregnant and Postpartum Women (PPW-PLT). This pilot program was designed to complement the residential PPW program by developing a continuum of family-centered care services in an outpatient setting. This spotlight compares program clients’ self-reported...

N-SSATS | National Survey of Substance Abuse Treatment Services
Collected Date: 2019
Report Type: State Report

These state profiles include data from facilities that reported to N-SSATS for the survey reference date March 29, 2019. The N-SSATS collects data on the location, characteristics, services offered, and number of clients (collected every other year) in treatment at alcohol and drug abuse treatment facilities (public and private) throughout...

N-SSATS | National Survey of Substance Abuse Treatment Services
Collected Date: 2018
Report Type: State Report

These state profiles includes data from facilities that reported to N-SSATS for the survey reference date March 30, 2018. The N-SSATS collects data on the location, characteristics, services offered, and number of clients (collected every other year) in treatment at alcohol and drug abuse treatment facilities (public and private) throughout...

N-SSATS | National Survey of Substance Abuse Treatment Services, NSDUH | National Survey on Drug Use and Health, TEDS | Treatment Episode Data Set
Collected Date: 2007-2012
Report Type: Short Report

This report uses the combined 2007 to 2012 National Surveys on Drug Use and Health (NSDUHs), the 2012 Treatment Episode Data Set (TEDS), and the 2012 National Survey of Substance Abuse Treatment Services (N-SSATS) to examine opioid use and treatment among women of childbearing age (aged 15 to 44).

N-SSATS | National Survey of Substance Abuse Treatment Services
Collected Date: 2010
Report Type: State Report

This state profile includes data from facilities in Arkansas that reported to N-SSATS for the survey reference date March 31, 2010. Data were collected on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse treatment facilities (both public and private) in Arkansas. In...

Part of the 2010 NSSATS State Profiles Collection
N-SSATS | National Survey of Substance Abuse Treatment Services
Collected Date: 2010
Report Type: State Report

This state profile includes data from facilities in Florida that reported to N-SSATS for the survey reference date March 31, 2010. Data were collected on the location, characteristics, services offered, and number of clients in treatment at alcohol and drug abuse treatment facilities (both public and private) in Florida. In...

Part of the 2010 NSSATS State Profiles Collection
DAWN | Drug Abuse Warning Network
Collected Date: 2005-2010
Report Type: Short Report

This Drug Abuse Warning Network (DAWN) short report looks at the estimated number of emergency room visits for adverse reactions involving involving the prescription sleep qie zolpidem for 2005 through 2010. The report focuses on gender, age groups and other pharmaceuticals such as pain relievers, other anti-anxiety and insomnia medications...

DAWN | Drug Abuse Warning Network
Collected Date: 2005-2010
Report Type: Short Report

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving buprenorphine between 2005 and 2011. Buprenorphine is used to treat dependence on heroin and narcotic pain medications. The report also shows buprenorphine-related visits broken out by non-medical use, adverse reactions and seeking detoxification...

DAWN | Drug Abuse Warning Network
Collected Date: 2005-2010
Report Type: Short Report

This Drug Abuse Warning Network (DAWN) short report shows the estimated number of emergency room visits involving attention deficit/hyperactivity disorder stimulant medications between 2005 and 2010. The report shows visits for nonmedical use, adverse reactions, visits involving other pharmaceuticals, illicit drugs or alcohol.